JP2000507922A5 - - Google Patents

Download PDF

Info

Publication number
JP2000507922A5
JP2000507922A5 JP1997529808A JP52980897A JP2000507922A5 JP 2000507922 A5 JP2000507922 A5 JP 2000507922A5 JP 1997529808 A JP1997529808 A JP 1997529808A JP 52980897 A JP52980897 A JP 52980897A JP 2000507922 A5 JP2000507922 A5 JP 2000507922A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1997529808A
Other languages
English (en)
Other versions
JP2000507922A (ja
Filing date
Publication date
Priority claimed from GBGB9603699.1A external-priority patent/GB9603699D0/en
Application filed filed Critical
Publication of JP2000507922A publication Critical patent/JP2000507922A/ja
Publication of JP2000507922A5 publication Critical patent/JP2000507922A5/ja
Pending legal-status Critical Current

Links

Description

Figure 2000507922
Figure 2000507922
Figure 2000507922
Figure 2000507922
JP9529808A 1996-02-21 1997-02-19 イブプロフェンの剤型 Pending JP2000507922A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9603699.1 1996-02-21
GBGB9603699.1A GB9603699D0 (en) 1996-02-21 1996-02-21 Therapeutic composition
PCT/EP1997/000841 WO1997030699A2 (en) 1996-02-21 1997-02-19 Dosage form of ibuprofen

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008276306A Division JP2009073847A (ja) 1996-02-21 2008-10-28 イブプロフェンの剤型

Publications (2)

Publication Number Publication Date
JP2000507922A JP2000507922A (ja) 2000-06-27
JP2000507922A5 true JP2000507922A5 (ja) 2004-11-25

Family

ID=10789176

Family Applications (2)

Application Number Title Priority Date Filing Date
JP9529808A Pending JP2000507922A (ja) 1996-02-21 1997-02-19 イブプロフェンの剤型
JP2008276306A Abandoned JP2009073847A (ja) 1996-02-21 2008-10-28 イブプロフェンの剤型

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008276306A Abandoned JP2009073847A (ja) 1996-02-21 2008-10-28 イブプロフェンの剤型

Country Status (25)

Country Link
US (1) US20020034540A1 (ja)
EP (1) EP0881899B1 (ja)
JP (2) JP2000507922A (ja)
KR (1) KR19990087084A (ja)
CN (1) CN1215989A (ja)
AT (1) ATE273696T1 (ja)
AU (1) AU722991B2 (ja)
BG (1) BG64165B1 (ja)
CA (1) CA2246344C (ja)
CZ (1) CZ298371B6 (ja)
DE (1) DE69730314T2 (ja)
DK (1) DK0881899T3 (ja)
ES (1) ES2227670T3 (ja)
GB (1) GB9603699D0 (ja)
HU (1) HUP9901454A3 (ja)
IL (1) IL125803A0 (ja)
NO (1) NO983825L (ja)
NZ (1) NZ331416A (ja)
PL (1) PL187383B1 (ja)
PT (1) PT881899E (ja)
RU (1) RU2182000C2 (ja)
SK (1) SK285032B6 (ja)
UA (1) UA55407C2 (ja)
WO (1) WO1997030699A2 (ja)
ZA (1) ZA971446B (ja)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US20030026835A1 (en) * 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
NZ508292A (en) * 1999-11-24 2002-08-28 Mcneil Ppc Inc Treatment of migraine symptoms with ibuprofen and salts thereof
KR100523242B1 (ko) * 2000-05-18 2005-10-24 한미약품 주식회사 이부프로펜을 함유하는 정제 조성물
EP1379226A2 (en) * 2001-04-10 2004-01-14 Zagros Pharma Inc. Animal model for evaluating analgesics
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
CA2510319A1 (en) * 2002-12-20 2004-07-15 Thomas J. Smith High pressure compaction for pharmaceutical formulations
US20040176234A1 (en) * 2003-03-07 2004-09-09 Baker Hughes Incorporated Method for improving separation operation of centrifuges and associated improved separation designs
US20080020042A1 (en) * 2003-10-14 2008-01-24 Peter Gruber Dosage form of sodium ibuprofen
UY28583A1 (es) * 2003-10-30 2005-05-31 Roche Consumer Health Ag Forma de presentación del naproxeno sodico
US20050266031A1 (en) * 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
US20080287456A1 (en) * 2004-05-28 2008-11-20 Imaginot Pty Ltd Oral Therapeutic Compound Delivery System
PL1916994T3 (pl) * 2004-06-29 2014-05-30 Takeda Pharma As Wytwarzanie kompozycji farmaceutycznej o szybkim uwalnianiu leków nierozpuszczalnych w wodzie i kompozycje farmaceutyczne otrzymywane sposobem według wynalazku
AU2005271036B2 (en) * 2004-08-12 2009-11-19 Reckitt Benckiser Healthcare (Uk) Limited Granules comprising paracetamol a NSAID and a sugar alcohol made by melt extrusion
US20070077297A1 (en) 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
CN101068532B (zh) * 2004-09-30 2012-03-14 斯科尔医药公司 布洛芬改进释放剂型
CA2589079A1 (en) * 2004-11-03 2006-06-01 Equitech Corporation Nsaid compositions exhibiting clinical superiority
ES2523988T3 (es) * 2005-02-09 2014-12-03 Boehringer Ingelheim International Gmbh Comprimidos recubiertos que contienen lisinato de ibuprofeno
EP1800667A1 (en) 2005-12-23 2007-06-27 Losan Pharma GmbH Rapidly solubilizing ibuprofen granulate
EP1863460B1 (en) 2005-03-22 2013-01-16 Losan Pharma GmbH Solubilized ibuprofen
JP2009508951A (ja) * 2005-09-19 2009-03-05 アルベマール・コーポレーシヨン カリウムイブプロフェンの極めて濃厚な注入可能な水溶液、その製造法および使用
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
JP2009517346A (ja) 2005-11-28 2009-04-30 イメイジノット ピーティーワイ エルティーディー 治療用化合物の経口送達系
KR101288924B1 (ko) * 2006-08-16 2013-07-24 에스에스 세야쿠 가부시키 가이샤 경구투여용 제제
FI20070521L (fi) 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
FI20080348A0 (fi) * 2008-02-15 2008-05-09 Atacama Labs Oy Uudenlainen farmaseuttinen formulaatio
US8951562B2 (en) * 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
JP5649305B2 (ja) * 2006-12-20 2015-01-07 テバ ウィメンズ ヘルス インコーポレイテッド プロゲスチンを含む口腔内崩壊性固体剤形ならびにその製造方法および使用方法
CA2723409C (en) * 2008-05-09 2016-11-08 Atacama Labs Oy Method and apparatus for dry granulation
US9629809B2 (en) * 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
JP5553830B2 (ja) * 2008-07-21 2014-07-16 アルベマール・コーポレーシヨン 高含量イブプロフェンナトリウム顆粒、その調製、および非発泡性固体剤形を調製する際のその使用
EP2323976A4 (en) * 2008-08-14 2014-07-02 Shasun Chemicals And Drugs Ltd ARYLALKYLCARBOXYLIC ACID SALTS, PROCESS FOR PREPARATION THEREOF AND GALENIC FORMS
AU2014200704C1 (en) * 2009-06-22 2018-12-06 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
AU2015264861C1 (en) * 2009-06-22 2017-11-16 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
MX2011013912A (es) * 2009-06-22 2012-02-23 Wyeth Llc Comprimidos de ibuprofeno de sodio y procedimientos de fabricacion de composiciones farmaceuticas que incluyen ibuprofeno de sodio.
JP5974469B2 (ja) * 2010-12-24 2016-08-23 ライオン株式会社 錠剤の製造方法
CN103102259B (zh) * 2011-12-23 2014-02-26 海南正瑞医药科技开发有限公司 一种布洛芬水合物晶体、及含该水合物晶体的药物组合物及其制备方法
JP6304896B2 (ja) * 2013-07-30 2018-04-04 ライオン株式会社 錠剤
EP2845850A1 (en) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
EP3164384B1 (en) 2014-07-02 2019-12-04 ObsEva S.A. Crystalline (3z,5s)-5-(hydroxymethyl)-1-[(2'-methyl-1,1'-biphenyl-4-yl)carbonyl]pyrrolidin-3-one o-methyloxime useful in methods of treating conditions related to the ot-r activity
EP2965746B1 (en) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
WO2017060920A1 (en) * 2015-10-05 2017-04-13 Strides Shasun Limited Pharmaceutical compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
DE3922441A1 (de) * 1989-07-07 1991-01-17 Pharmatrans Sanaq Ag Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung
RU2145219C1 (ru) * 1991-05-13 2000-02-10 Дзе Бутс Компани ПЛС Фармацевтическая композиция, содержащая s(-)-2-(4-изобутилфенил)пропионат натрия, способ получения натриевой соли энантиомера 2-(4-изобутилфенил)пропионовой кислоты, s(-)-2-(4-изобутилфенил)пропионат натрия дигидрат
DE4216756C2 (de) * 1992-05-21 1994-08-25 Pharmatrans Sanaq Ag 2-Arylpropionsäure-Zubereitungen und Verfahren zu ihrer Herstellung
EP0607467B1 (de) * 1992-12-01 1999-06-02 Spirig Ag Pharmazeutische Präparate S(+)-Ibuprofen enthaltende Arzneimittel

Similar Documents

Publication Publication Date Title
JP2000506431A5 (ja)
JP2001510326A5 (ja)
JP2000509578A5 (ja)
JP2000500076A5 (ja)
JP2000507577A5 (ja)
JP2000501324A5 (ja)
JP2000509498A5 (ja)
JP2000516913A5 (ja)
JP2000500055A5 (ja)
JP2000500026A5 (ja)
JP2001504900A5 (ja)
JP2000502472A5 (ja)
JP2000501338A5 (ja)
JP2001500292A5 (ja)
JP2000516851A5 (ja)
JP2000514077A5 (ja)
JP2000507922A5 (ja)
JP2000502485A5 (ja)
JP2000502425A5 (ja)
JP2000501774A5 (ja)
JP2000502570A5 (ja)
JP2000502568A5 (ja)
JP2001500486A5 (ja)
JP2000502316A5 (ja)
JP2000502714A5 (ja)